Table1_Adverse event profile of albumin-bound paclitaxel: a real-world pharmacovigilance analysis.DOCX

Table1_Adverse event profile of albumin-bound paclitaxel: a real-world pharmacovigilance analysis.DOCX

Background<p>Abraxane plays a crucial role in the treatment of various types of cancer, despite the considerable attention it has garnered for its adverse drug events (ADEs). Nevertheless, there is currently a significant lack of comprehensive real-world pharmacovigilance studies on the ADEs a...

Full description

Saved in:
Bibliographic Details
Main Author: Yuanqiong Duan (16022084) (author)
Other Authors: Ying Wang (11406) (author), Shentao Lu (19956195) (author), Mei Zeng (293866) (author), Lubin Liu (17619118) (author), Qian Dai (2640862) (author), Rutie Yin (12077955) (author)
Published: 2024
Subjects:
Pharmacology
Basic Pharmacology
Clinical Pharmacology and Therapeutics
Clinical Pharmacy and Pharmacy Practice
Pharmaceutical Sciences
Pharmacogenomics
Toxicology (incl. Clinical Toxicology)
Pharmacology and Pharmaceutical Sciences not elsewhere classified
albumin-bound paclitaxel
adverse drug events
FDA adverse event reporting system
signal mining
pharmacovigilance analysis
real-world study
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items